• search
For Quick Alerts
For Daily Alerts

Study says Oxford’s COVID-19 vaccine produced strong response in older adults


New Delhi, Nov 19: The COVID-19 vaccines that the University of Oxford is developing with AstraZeneca has produced a strong immune response in older adults in an early study along with pivotal findings from the final phase of trials that are expected in the coming weeks.

The results that were published in The Lancet medical journal shed more light on the preliminary data released in recent months showing the experimental shot generated an immune response in older people who are higher risk.

Study says Oxford’s COVID-19 vaccine produced strong response in older adults

Researchers are still awaiting late-stage trial results that will show whether the Astra-Oxford vaccine can meet the high bar set by companies like Moderna and Pfizer.

Who will get COVID-19 vaccine first in India?Who will get COVID-19 vaccine first in India?

An Oxford researcher wrote in a statement that inducing robust immune responses in older adults has been a long-standing challenge.

"To show this vaccine technology is able to induce these responses -- in the age group most at risk from severe Covid-19 disease offers hope that vaccine efficacy will be similar in younger and older adults," Angela Minassian, an investigator at Oxford, wrote in a statement.

    Nagrota encounter arms haul, BBC to probe Diana interview & more news | Oneindia News

    The results of Oxford's phase-2 study show that the vaccine is better tolerated in older people and produces similar immune response in old and young adults. The study involved 560 adults of which 240 were above the age of 70.

    For Daily Alerts
    Get Instant News Updates
    Notification Settings X
    Time Settings
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X